Suhong Xie - Concepedia

Author

Suhong Xie

Fudan University Shanghai Cancer Center ORCID

Also Known As

S Xie, S. Xie, SUHONG XIE, Shichao Xie, Shuyuan Xie, Su-Hong Xie, Suhong Xie

Publications

757

Citations

H-Index

Concepts

All Affiliations

Fudan University Shanghai Cancer Center Shanghai Medical College of Fudan University Fudan University Zhongshan Hospital Minhang District Central Hospital

About

Suhong Xie is an author at Fudan University Shanghai Cancer Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	201
2	Cell Biology	6	6	176
3	Health Sciences	3	3	58
4	Obstetrics	3	3	86
5	Pathology	1	1	25

Suhong Xie

Publications

669

Citations

H-Index

Page 1

	Year	Citations
The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphoma Fang Xia, Bing Xiu, Zhi-Zhang Yang, Medicine	2017	59
Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer Miaomiao Chen, Hongqin Zhang, Guihong Zhang, Biochemical and Biophysical Research Communications Cancer ResearchBreast OncologyCell DeathBreast CancerTumor Suppressor	2018	57
APE1 overexpression promotes the progression of ovarian cancer and serves as a potential therapeutic target Xuemei Wen, Renquan Lu, Suhong Xie, Cancer Biomarkers	2016	42
Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma Yanchun Wang, Wang HuiJie, Shaokun Pan, Journal of Cancer	2018	41
Inhibition of MCM2 enhances the sensitivity of ovarian cancer cell to carboplatin Minjie Deng, Jiajun Sun, Suhong Xie, Molecular Medicine Reports Chemotherapy ResistanceOvarian Cancer CellMcm2 ExpressionMedicineGynecology	2019	39
Human leukocyte antigen‐E alleles and expression in patients with serous ovarian cancer Hui Zheng, Renquan Lu, Suhong Xie, Cancer Science	2015	37
VHL regulates the sensitivity of clear cell renal cell carcinoma to SIRT4-mediated metabolic stress via HIF-1α/HO-1 pathway Ying Tong, Jinyan Kai, Shuo Wang, Cell Death and Disease	2021	37
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer Yixuan Liu, Keyu Zhu, Xiaolin Guan, Journal of Ovarian Research	2021	34
Elevated serum HER‐2 predicts poor prognosis in breast cancer and is correlated to ADAM10 expression Hui Zheng, Ailing Zhong, Suhong Xie, Cancer Medicine	2019	29
YY1-C/EBPα-miR34a regulatory circuitry is involved in renal cell carcinoma progression Wenhao Weng, Minli Wang, Suhong Xie, Oncology Reports	2014	27

Page 1